RNA BIOCHEMISTRY IS ONE OF THE MOST PROMISING AREAS OF MEDICINAL INNOVATION

First Health Pharmaceuticals has a leading position in the field of advanced RNA biochemistry. We aim to further develop our portfolio of highly active patented RNA Helicase inhibiting lead compounds and bring revolutionary pharmaceuticals to the market that will offer new hope for patients suffering from some of the most challenging diseases of our time.

HIV RESERVOIR REDUCTION

First Health Pharma developed the first ever generation of Translation Inhibitor compounds effective against HAART resistant HIV strains and is investigating potential strategies to be applied in a HIV Shock & Kill approach.

Read more

RNA TECHNOLOGY

The translation of RNA to proteins is fundamental for cell survival and replication, thus First Health Pharmaceuticals has set its RNA Research priorities on the development of RNA Helicase inhibiting lead compounds.

Read more

CANCER TARGETS

DDX3 RNA helicase has remarkable oncogenic properties. It is overexpressed in the malignant types of Breast and Lung cancer. Our DDX3 inhibitors can be considered apoptosis-inducing targeted antitumor agents.

Read more

Visit our news section for updates

New Laboratory Facilities in Italy

February 23, 2021

Besides our Research and Development in The Netherlands, First Health Pharmaceuticals has important collaborations worldwide, especially in countries such as India and Italy. Recently we opened new laboratory facilities...

WORLD AIDS DAY 2020

December 1, 2020

World AIDS Day occurring each December 1, helps reminding civil society and governments every year that HIV is still relevant. Its awareness-raising mission includes activities that take place around...

First Health Pharma participates in a new CoViD-19 research project in the Netherlands

July 10, 2020

Clinically-validated nasal airway epithelial cell models for COVID-19 high throughput drug development. As the unparalleled global health crises caused by the novel coronavirus SARS-CoV-2 seems not to have come...

Host factor-based early stage diagnosis of high risk CoViD-19 patients

March 13, 2020

A few days after the coronavirus disease 2019 (CoViD-19) outbreak turned out to be a pandemic, all of a sudden it became necessary to tackle the whole issue globally....

Sudden Coronavirus spread in China urges exploration of new cure pathways

January 23, 2020

The spread of novel coronavirus in China has been confirmed by Chinese authorities. After more than 290 sickened people and presumably more than 1700 infected people, the latest updates...

We’re hiring!

December 5, 2019

Careers at First Health Pharmaceuticals Interested in joining us? Please have a look at our current vacancies. About First Health Pharma First Health Pharmaceuticals B.V. is a biotech company...